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Abstract The effects of nitric oxide on the activities of
thapsigargin-sensitive sarcoplasmic reticulum Ca2+-ATPase
(SERCA) and Ca2+ uptake by sarcoplasmic reticulum (SR)
membranes prepared from white skeletal muscle of rabbit
femoral muscle were studied. Pretreatment of the SR prepara-
tions with nitric oxide at concentrations of up to 250 WM for
1 min decreased the SERCA activity concentration dependently,
and also decreased their Ca2+ uptake. Both these effects of nitric
oxide were reversible. Inhibitors of guanylyl cyclase and protein
kinase G (PKG) had no significant effect on the nitric oxide-
induced inhibitions of SERCA and Ca2+ uptake. Moreover,
dithiothreitol did not reverse the inhibitory effects of nitric oxide
on SERCA and Ca2+ uptake. These findings suggest that nitric
oxide inhibits SERCA, mainly SERCA 1, of rabbit femoral
skeletal muscle by an action independent of the cyclic GMP-
PKG system or oxidation of thiols, and probably by a direct
action on SERCA protein.
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1. Introduction
Nitric oxide is generated in the conversion of L-arginine to
L-citrulline catalyzed by nitric oxide synthase. Three isoforms
of nitric oxide synthase are known: a neural type designated
as nNOS (NOS-1), an inducible type iNOS (NOS-2) and an
endothelial cell type eNOS (NOS-3). nNOS and eNOS are
called constitutive nitric oxide synthase (cNOS) because of
their constitutive expressions (for reviews, see [1,2]). cNOS
activity is dependent on Ca2/calmodulin [3] and requires tet-
rahydrobiopterin [4], whereas iNOS activity is regulated by
gene expression inducible by immunological stimuli [1,2].
nNOS has been puri¢ed from rat cerebellum [5] and is located
immunohistochemically in the brain, retina, myenteric plexus
of the intestine, adrenal glands and vascular endothelial cells
[3]. In subsequent studies it was also found in the epithelium
of the bronchi and trachea [6], and also in rat skeletal muscle,
type II (fast) ¢ber [7] and type I (slow) ¢ber [8^10] cell mem-
branes. The physiological signi¢cance of nitric oxide in skel-
etal muscle was suggested from the ¢nding that contractile
function was augmented by inhibitors of nitric oxide synthase
and depressed by nitric oxide donors [7].
Increase in the cytoplasmic concentration of Ca2 ions re-
leased from the sarcoplasmic reticulum (SR) results in muscle
contraction. Activation of sarcoplasmic reticulum Ca2-AT-
Pase (SERCA) decreases the Ca2 concentration by uptake of
cytoplasmic Ca2 ions into the SR and results in muscle re-
laxation [11]. One isoform of SERCA, SERCA 1, is present in
the sarcolemma of type II ¢bers [12,13] and another isoform,
SERCA 2, in the cardiac muscle, slow ¢bers of skeletal muscle
and smooth muscle [14]. The mechanism of regulation of car-
diac SERCA 2 activity is known: a regulatory protein, phos-
pholamban, inhibits its activity by binding to its catalytic
subunit and phosphorylation of phospholamban induced by
cyclic AMP-dependent protein kinase reverses this inhibition
[15,16]. However, the mechanism regulating SERCA 1 activity
has not been studied. Here we report studies on the e¡ect of
nitric oxide on the activity of SERCA 1 to determine the
mechanism of the e¡ect of nitric oxide on fast ¢bers of skel-
etal muscle.
2. Materials and methods
2.1. Preparation of sarcoplasmic reticulum (SR) membranes from
rabbit skeletal muscle
SR membranes were prepared as described by Eletr and Inesi [17].
Soon after excision of white skeletal muscle from rabbit hind legs, the
tissue was washed and cooled in 0.1 mM EDTA, pH 7.0. Samples of
150 g of trimmed muscle were then homogenized in 450 ml of Me-
dium 1 (10 mM histidine, 10% sucrose, 0.1 mM EDTA, pH 7.0) for
15-s periods every 5 min, for 1 h. During this time, the pH was
adjusted with a few drops of 5% NaOH when necessary. The homog-
enate was centrifuged at 15 000Ug for 20 min. The supernatant was
collected and ¢ltered through several layers of washed gauze (1-inch
thick ¢lter) to eliminate low-density lipid aggregates. The ¢ltered sus-
pension was then centrifuged at 40 000Ug for 90 min and the resulting
precipitate was resuspended in 55 ml of Medium 2 (10 mM histidine,
0.6 M KCl, pH 7.0).
After incubation for 40 min at 2^4‡C, the suspension was centri-
fuged at 15 000Ug for 20 min. Then the top layer (approx. 10% of the
total volume) was carefully discarded, to remove low-density lipid
aggregates that could still be associated with the preparaton. The
remaining supernatant was then collected and recentrifuged at
40 000Ug for 90 min. This resulting precipitate was resuspended in
20 ml of Medium 3 (0.88 M sucrose, 10 mM MOPS, pH 7.0). The
entire procedure was carried out at 2^4‡C.
2.2. Measurement of thapsigargin-sensitive Ca2 +-ATPase (SERCA)
activity
SERCA activity in SR membrane preparations was measured by
monitoring the release of 32Pi from [Q-32P]ATP (Amersham, PB218).
The basic assay mixture consisted of membranes (10 Wg of protein),
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100 mM KCl, 50 mM Tris-HCl (pH 7.4), 2 mM ATP (containing
100 WM KOH and [Q-32P]ATP), 3 mM MgCl2, 2 WM A23187, 1 mM
NaN3, and appropriate amounts of CaCl2 and EGTA (adjusted to pH
7.4 with up to 29 WM KOH) to produce the required free Ca2 con-
centration calculated with the software developed by Horiuchi [18].
Assay of SERCA activity was started by addition of 100 Wl of the SR
preparation to 400 Wl of the basic assay mixture and carried out for
various incubation periods at 37‡C. Thapsigargin-sensitive SERCA
activity was de¢ned as the di¡erence between the SERCA activities
measured in the presence and absence of 100 nM thapsigargin, as
previously described [19]. All assays were started after 5 min preincu-
bation at 37‡C with or without thapsigargin.
2.3. Measurement of thapsigargin-sensitive Ca2 + uptake activity
Uptake of 45Ca was measured at 25‡C by the micro¢ltration meth-
od described by Zhang et al. [20]. The basic reaction mixture con-
tained 20 mM MOPS (pH 7.0), 100 mM KCl, 5 mM MgCl2, 5 mM
potassium oxalate, 3 mM ATP, membrane vesicles (up to 10 Wg/ml),
and appropriate amounts of CaCl2 and EGTA to produce the re-
quired free Ca2 concentration [18]. Thapsigargin-sensitive Ca2 up-
take activity was de¢ned as the di¡erence between the Ca2 uptake
activities measured in the presence and absence of 500 nM thapsigar-
gin. The reaction was started by addition of oxalate and ATP after
5 min of preincubation at 37‡C with or without thapsigargin and was
terminated at intervals by ¢ltration through Millipore ¢lters (0.45 Wm).
The ¢lters were washed twice with 2 ml of 2 mM ice cold LaCl3 and
10 mM MOPS (pH 7.0), and the remaining radioactivity was meas-
ured in a scintillation counter.
2.4. Drugs
Rp-isomer (Rp-8 bromo cyclic GMPS) was purchased from Biolog
Life Sci., Bremen, Germany. 6-(Phenylamino)-5,8-quinolinedione
(LY83583) was from Res. Biochem., MA, USA. Inositol 1,4,5-tris-
phosphate (IP3) and ryanodine were from Funakoshi, Tokyo. Ca¡eine
was from Wako Pure Chemicals, Osaka, Japan. Heparin was from
Sigma, St. Louis, MO, USA. (DL)-(E)-Ethyl-2-[(E)-hydroxyimino]-5-
nitro-3-hexeneamine (NOR3) was from Dojindo Laboratories, Kuma-
moto, Japan. Gaseous nitric oxide was dissolved in the incubation
medium just before experiments, as described previously [21].
3. Results
3.1. E¡ect of nitric oxide on thapsigargin-sensitive Ca2+-
ATPase (SERCA) activity in rabbit skeletal muscle
Sarcoplasmic reticulum (SR) preparations obtained from
rabbit femoral muscle exhibited thapsigargin-sensitive SER-
CA activity: the activity evaluated as Pi liberation from
ATP was 3.2 þ 0.3 Wmol/min/g protein (n = 6) and was con-
stant during a 30-min incubation period under the present
experimental conditions (Fig. 1). Pretreatment of the SR prep-
arations with 250 WM nitric oxide for 1 min inhibited the
SERCA activity, the extent and duration of inhibition de-
pending on the nitric oxide concentration used in the pretreat-
ment period (Fig. 1). After inhibition, the activity was grad-
ually but completely restored to the control level (Fig. 1).
Thus, the inhibitory e¡ect of nitric oxide was reversible under
the present conditions. Since nitric oxide is readily oxidized
under the present experimental conditions, we next examined
the e¡ect of NOR3 which liberates nitric oxide continuously
from its molecule. NOR3 also inhibited the activity in a con-
centration dependent manner, but its inhibitory e¡ect was
constant during a 25-min incubation period (Fig. 2).
In another series of experiments, we examined the e¡ects of
nitric oxide on Ca2 uptake by SR preparations to con¢rm its
inhibitory e¡ect on SERCA activity. The SR preparations
exhibited thapsigargin-sensitive, ATP-dependent uptake of
45Ca2 ions and the uptake reached a maximun within about
5 min (Fig. 3A). Pretreatment of the SR preparations with
200 WM nitric oxide inhibited the Ca2 uptake activity. The
amount of Ca2 taken up gradually returned to the control
level about 15 min after the preincubation period (Fig. 3A).
The Ca2 uptake activity was completely restored to the con-
trol level about 15 min after pretreatment of the SR prepara-
tions with 200 WM nitric oxide (Fig. 4). Thus, Ca2 uptake
was inhibited reversibly by nitric oxide. Pretreatment of the
preparations with nitric oxide in the presence of 1 WM hemo-
globin did not a¡ect the Ca2 uptake activity (data not
shown).
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Fig. 1. E¡ects of nitric oxide on activity of thapsigargin-sensitive
Ca2-ATPase (SERCA) of rabbit SR preparations. Preparations
were preincubated without (control) or with various concentrations
of nitric oxide (NO) for 1 min. Then, 100-Wl volumes of prepara-
tions were incubated in 400 Wl of assay mixture in the presence of
5 WM free Ca2 ions and 2 WM A23187 to measure SERCA activ-
ity. Nitric oxide added during pretreatment was diluted 5-fold with
the incubation mixture. SERCA activity was measured over a peri-
od of 30 min. Points and bars represent means and standard devia-
tions of values in four to six separate preparations.
Fig. 2. E¡ect of NOR3 on SERCA activity of rabbit SR prepara-
tions. The SERCA activity of SR preparations was measured in the
absence (control) or presence of 1 or 2 WM NOR3 over a period of
25 min. For further details, see Section 2. Points and bars represent
means and standard deviations of values in four to six separate ex-
periments.
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3.2. E¡ects of inhibitors of guanylyl cyclase and cyclic GMP-
dependent protein kinase (PKG) on nitric oxide-induced
inhibition of SERCA activity
Since nitric oxide is known to induce various physiological
and pathophysiological events via a cyclic GMP-PKG path-
way, we studied the e¡ects of an inhibitor (LY 83583) of
guanylyl cyclase and an inhibitor (Rp-8 bromo cyclic
GMPS) of PKG on nitric oxide-induced inhibition of SERCA
activity. LY 83583 at 1 WM almost completely inhibited in-
crease by dimethylphenylpiperazinium-induced cyclic GMP in
rat proximal colon [22], and Rp-8 bromo cyclic GMPS at
10 WM completely inhibited the activity of PKG puri¢ed
from porcine aorta [23], but had no signi¢cant e¡ects on the
activity of SERCA in SR preparations with or without pre-
treatment with nitric oxide (Fig. 5). They also had no signi¢-
cant e¡ect on the Ca2 uptake activity of untreated or nitric
oxide-pretreated SR preparations (data not shown).
3.3. E¡ects of reductants on nitric oxide-induced inhibition of
SERCA activity
Nitric oxide is known to generate reactive oxidants such as
NO2 and NO3 by oxidation [24]. Active oxygens inhibit many
thiol enzymes by oxidizing their thiols and reductants protect
these enzymes from oxidation [25^27]. Therefore, we studied
whether dithiothreitol (DTT) reverses the inhibition of SER-
CA activity by nitric oxide. DTT at 10 mM did not a¡ect the
SERCA activity of untreated or nitric oxide-pretreated SR
preparations (Fig. 3B). It also did not a¡ect the 45Ca2 uptake
activity of untreated or nitric oxide-pretreated SR prepara-
tions (Fig. 3A).
3.4. E¡ects of agonists and antagonists of SR Ca2+ channels on
nitric oxide-induced inhibition of SERCA activity
The above ¢ndings suggest that nitric oxide inhibits Ca2
uptake into the SR by inhibiting SERCA activity. However, it
is also possible that it activates Ca2 channels present in the
SR membrane, and so increases Ca2 release from the SR
with resultant decreases of Ca2 uptake into the SR. In
fact, agonists of SR Ca2 channels, ca¡eine at 20 mM and
IP3 at 10 WM, decreased 45Ca2 uptake into SR preparations
by their e¡ects in activating Ca2 releasing channels (Fig. 6A).
If the inhibitory e¡ect of nitric oxide on Ca2 uptake involves
activation of SR Ca2 channels, antagonists of these SR Ca2
channels should counteract the nitric oxide-induced inhibition
of 45Ca2 uptake. However, neither an antagonist of IP3-sen-
sitive Ca2 channels (heparin) nor one of ca¡eine-sensitive
Ca2 channels (ryanodine) had any signi¢cant e¡ect on the
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Fig. 3. E¡ects of nitric oxide and dithiothreitol (DTT) on Ca2 up-
take and SERCA activity of rabbit SR preparations. A: Ca2 up-
take activities of SR preparations preincubated without (control) or
with 200 WM nitric oxide were measured in the absence or presence
of 10 mM DTT. The amounts of Ca2 taken up by the SR prepara-
tions during the indicated incubation periods were expressed in
mmol Ca2/mg protein. Points and bars represent means and stand-
ard deviations for four to six separate measurements. B: Activities
of SERCA of SR preparations preincubated without (control) or
with 100 WM nitric oxide for 1 min were measured in the absence
or presence of 10 mM DTT. For further details, see legend of Fig.
1. Note that 10 mM DTT did not in£uence the SERCA or Ca2
uptake activity.
Fig. 4. Recovery of Ca2 uptake activity of rabbit SR preparations
from nitric oxide-induced inhibition. The SR preparations were pre-
incubated without (a) or with (b) 200 WM nitric oxide for 1 min.
Then they were incubated in assay mixture in the presence of 5 WM
Ca2 ions for the indicated times. Ca2 uptake activity was deter-
mined by measuring the amount of Ca2 taken up into the SR
preparations during a further 45-s incubation period and is ex-
pressed as mmol Ca2 taken up per min per mg protein. Points and
bars show means and standard deviations for four to six separate
measurements. Note that nitric oxide-induced inhibition of Ca2 up-
take activity was completely reversed after incubation for 13 min.
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inhibitory e¡ect of nitric oxide (Fig. 6B). Moreover, these
agonists and antagonists had no signi¢cant e¡ect on the SER-
CA activity of SR preparations in the absence or presence of
nitric oxide (data not shown).
3.5. E¡ects of nitric oxide on ouabain-sensitive Na+,K+-
ATPase activity of a chicken kidney homogenate
The e¡ect of nitric oxide on another P type ATPase,
Na,K-ATPase, was also examined. Nitric oxide did not
a¡ect the activity of ouabain-sensitive Na,K-ATPase of a
chicken kidney homogenate (data not shown).
4. Discussion
A role of nitric oxide in skeletal muscle contraction was ¢rst
suggested by studies on rat diaphragm [5], namely, electrical
stimulation-induced contraction of the muscle was signi¢-
cantly augmented by inhibitors of nitric oxide synthase and
inhibited by exogenous nitric oxide donors. Immunohisto-
chemical studies showed prominent staining of fast ¢bers of
the diaphragm with antibodies against nNOS. The intracellu-
lar mechanism of the inhibitory action of nitric oxide on skel-
etal muscle is unknown. In the present study, we examined the
e¡ect of nitric oxide on the SERCA activity of SR prepara-
tions from fast ¢bers of rabbit femoral muscle which express
SERCA, mainly the SERCA 1 isoform. The results clearly
showed that nitric oxide inhibited the SERCA activity in
SR preparations. Results on nitric oxide-induced inhibition
of the Ca2 uptake activity of the SR preparations supported
this idea. We suppose that depression of SERCA activity
resulted in decrease or depletion of Ca2 stores in the SR
and consequent inhibition of muscle contraction.
In the present study, the e¡ects of nitric oxide at concen-
trations of up to 250 WM on SERCA activity, evaluated by
hydrolysis of ATP and 45Ca2 uptake, were reversible, but the
e¡ect of the nitric oxide persistently releasing compound
NOR3 was sustained. The reversible nature of nitric oxide-
induced inhibition seems to be due to loss of nitric oxide from
the incubation medium by its oxidation. However, although
nitric oxide is oxidized rapidly (within several seconds), its
e¡ect on SERCA activity persists for some time. The time
required for recovery from the inhibitory e¡ects of nitric oxide
treatment was related with the concentration of nitric oxide.
There are reports that thiol residues such as glutathione and
cysteine are dehydrated by O-iodide benzoic acid and perox-
ide, thereby resulting in formation of inter-molecular disul¢de
bonds [28,29]. Another modi¢cation of thiol residues by nitric
oxide is S-nitrosylation. S-Nitrosylation of thiol residues of
ryanodine receptors puri¢ed from canine heart caused pro-
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Fig. 5. E¡ects of LY 83583 and Rp-8 Br cGMPS on nitric oxide-in-
duced inhibition of SERCA activity. Rabbit SR preparations were
preincubated without (control) or with 100 WM nitric oxide, 1 WM
LY 83583, 10 WM Rp-8 Br cyclic GMPS, nitric oxide plus LY
83583 or nitric oxide plus Rp-8 Br cyclic GMPS for 1 min. Then
preparations were incubated for 30 min to measure SERCA activity.
The drugs were diluted 5-fold in the incubation mixture.
Fig. 6. E¡ects of ca¡eine, IP3, ryanodine and heparin on Ca2 up-
take activity and reduction of Ca2 uptake activity by nitric oxide
in rabbit SR preparations. A: The Ca2 uptake activity of SR prep-
arations was measured in the absence or presence of 20 mM ca¡eine
or 10 WM IP3. B: The Ca2 uptake activity of SR preparations pre-
incubated without (control) or with 200 WM nitric oxide for 1 min
was measured in the absence or presence of 10 WM ryanodine or
0.3 mg/ml heparin. Ca2 taken up into the SR preparations during
various incubation periods is shown as mol Ca2/mg protein. Points
and bars show means and standard deviations for four to six sepa-
rate measurements.
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gressive channel activation [30]. The nitrosylation of GAPDH
by nitric oxide was closely related to inhibition of its activity
[31]. However, the inhibitory e¡ect of nitric oxide on SERCA
does not seem to be related to modi¢cations of thiols, since
DTT did not reverse the reduced activities of SERCA and
Ca2 uptake induced by nitric oxide. Furthermore, ryanodine
did not a¡ect the inhibitory e¡ect of nitric oxide on Ca2
uptake. It is reported that Ca2 release from skeletal muscle
SR via ryanodine receptors is activated by ca¡eine, and re-
duced by nitric oxide donors [32]. Therefore, nitric oxide may
inhibit Ca2 release in the absence of ca¡eine. However, in the
present study, nitric oxide apparently inhibited rather than
increased Ca2 uptake, and ryanodine and heparin did not
a¡ect Ca2 uptake in the presence of nitric oxide. Thus, these
inhibitory e¡ects of nitric oxide also seem to be independent
of activation or inhibition of SR Ca2 channels. Since nitric
oxide did not a¡ect Na,K-ATPase in a chicken kidney
homogenate, its inhibitory e¡ect on SERCA activity does
not seem to be common to P type ATPases.
Interestingly, in rat diaphragm fast ¢bers, the stimulatory
e¡ect of an inhibitor of nNOS on contraction induced by
electrical stimulation was partially counteracted by a cyclic
GMP analogue, 8-bromo cyclic GMP, and a phosphodiester-
ase inhibitor, dipyridamole, and the guanylyl cyclase inhibitor
LY 83583 increased the contraction induced by electrical stim-
ulation [5]. These results suggest that the cyclic GMP-PKG
pathway is involved in the intracellular mechanism of the
inhibitory action of nitric oxide. However, our ¢nding of
the inhibitory e¡ect of nitric oxide on SERCA activity is in-
compatible with such a pathway, since LY 83583 and a PKG
inhibitor, Rp-8 bromo cyclic GMPS, did not a¡ect the inhib-
itory e¡ect of nitric oxide on SERCA activity. Nitric oxide
may a¡ect SERCA protein directly. Thus, although inhibition
by nitric oxide of SERCA, mainly SERCA-1, seems to be one
possible mechanism for its inhibition of skeletal muscle con-
traction, further studies are needed on the relationship be-
tween inhibition of SERCA activity and muscle contraction.
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